Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$14K Hold
266
0.01% 197
2019
Q2
$13K Hold
266
0.01% 192
2019
Q1
$14K Hold
266
0.01% 190
2018
Q4
$13K Hold
266
0.02% 167
2018
Q3
$13K Hold
266
0.01% 216
2018
Q2
$13K Hold
266
0.01% 224
2018
Q1
$13K Hold
266
0.01% 242
2017
Q4
$12K Sell
266
-128
-32% -$5.91K 0.01% 226
2017
Q3
$20K Sell
394
-228
-37% -$11.6K 0.01% 190
2017
Q2
$36K Sell
622
-128
-17% -$6.82K 0.02% 158
2017
Q1
$42K Hold
750
0.03% 132
2016
Q4
$40K Sell
750
-128
-15% -$6.32K 0.02% 135
2016
Q3
$50K Hold
878
0.03% 129
2016
Q2
$50K Hold
878
0.03% 140
2016
Q1
$48K Hold
878
0.03% 130
2015
Q4
$48K Hold
878
0.03% 139
2015
Q3
$46K Hold
878
0.02% 126
2015
Q2
$49K Hold
878
0.02% 125
2015
Q1
$52K Sell
878
-516
-37% -$29.6K 0.02% 137
2014
Q4
$77K Sell
1,394
-27,888
-95% -$1.56M 0.03% 92
2014
Q3
$1.68M Buy
29,282
+387
+1% +$23.7K 0.63% 46
2014
Q2
$1.93M Buy
28,895
+380
+1% +$25.7K 0.6% 51
2014
Q1
$1.9M Sell
28,515
-595
-2% -$40.2K 0.63% 43
2013
Q4
$1.94M Buy
29,110
+4,383
+18% +$284K 0.66% 40
2013
Q3
$1.57M Sell
24,727
-1,397
-5% -$89.9K 0.64% 37
2013
Q2
$1.64M Buy
+26,124
New +$1.66M 0.69% 28

Other funds holding GSK

Shamrock Asset Management's GSK Position: Q3 2019 in Review

Shamrock Asset Management held its GSK (GSK) position steady in Q3 2019 at 266 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #197.

Shamrock Asset Management first reported a position in GSK in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.94M in Q4 2013. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Shamrock Asset Management held 266 shares of GSK worth $14K as of Q3 2019.
  • Shamrock Asset Management left its GSK share count unchanged in Q3 2019.
  • GSK made up 0.01% of Shamrock Asset Management's portfolio in Q3 2019, its #197 holding.
  • Shamrock Asset Management first reported a position in GSK in Q2 2013 and has held it in 26 quarters since.
  • Shamrock Asset Management's GSK position peaked at $1.94M in Q4 2013.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.